L13.8 – Bullous Disorders | ICD-10 Explanation
L13.8 is the ICD-10 code for other specified bullous disorders – skin conditions characterised by blister formation that do not fall into other specific bullous disease categories.
Things worth knowing about "L13.8"
L13.8 is the ICD-10 code for other specified bullous disorders – skin conditions characterised by blister formation that do not fall into other specific bullous disease categories.
What is ICD-10 Code L13.8?
The ICD-10 code L13.8 refers to other specified bullous disorders. It belongs to the group of bullous skin diseases (L10–L14) and is used when a blistering skin condition is present that does not correspond to any of the commonly coded bullous dermatoses but can still be clinically specified.
Bullous disorders are a heterogeneous group of skin diseases characterised by the formation of bullae (large blisters) or vesicles (small blisters) on the skin and/or mucous membranes. These can be triggered by autoimmune processes, genetic defects, medications, infections, or external stimuli.
Causes
The causes of conditions classified under L13.8 are diverse:
- Autoimmune reactions: The immune system attacks structural proteins of the skin, leading to blister formation.
- Genetic factors: Inherited defects in skin structural proteins can cause blistering reactions.
- Drug-induced reactions: Certain medications can trigger blistering skin reactions.
- Infectious triggers: Bacterial or viral infections can in rare cases cause bullous dermatoses.
- Physical stimuli: Excessive friction, UV radiation, or thermal irritation can cause blisters to form.
Symptoms
The hallmark symptom of all bullous disorders is the formation of blisters on the skin. Depending on the underlying condition, the following symptoms may occur:
- Widespread or localised blisters containing serous, haemorrhagic, or purulent fluid
- Erosions and crusts after blisters rupture
- Itching, burning, or pain in the affected area
- Involvement of mucous membranes (e.g., oral cavity, eyes, or genitals)
- Systemic symptoms such as fever or fatigue when internal organs are affected
Diagnosis
The diagnosis of bullous disorders requires a thorough clinical and laboratory-based evaluation:
- Clinical examination: Assessment of the location, size, and nature of the blisters and mucous membrane involvement.
- Skin biopsy: Histological examination to determine the level of blister formation (intraepidermal vs. subepidermal) and the type of inflammation.
- Direct immunofluorescence (DIF): Detection of antibody or complement deposits in the skin; essential for diagnosing autoimmune forms.
- Indirect immunofluorescence (IIF) and ELISA: Detection of circulating autoantibodies in the blood.
- Nikolsky sign: A clinical test in which lateral pressure on healthy skin induces blister formation; positive in certain acantholytic forms.
Treatment
Treatment depends on the specific diagnosis within the L13.8 code and the severity of the condition:
- Corticosteroids (systemic or topical): Frequently used to control inflammatory reactions and reduce blister formation.
- Immunosuppressants: In autoimmune conditions, agents such as azathioprine, mycophenolate mofetil, or cyclophosphamide are used.
- Biologics: Monoclonal antibodies (e.g., rituximab) are used in treatment-refractory autoimmune forms.
- Local wound care: Careful management of ruptured blisters to prevent secondary infections.
- Treatment of the underlying cause: Discontinuing causative medications, treating infections, or avoiding physical triggers.
Distinction from Other ICD-10 Codes
The code L13.8 is used for bullous disorders that do not fall into the more specific categories of ICD-10 group L10–L14. Related codes include:
- L10–L12: Pemphigus disorders and bullous pemphigoid
- L13.0: Dermatitis herpetiformis (Duhring disease)
- L13.1: Subcorneal pustular dermatosis
- L14: Bullous disorders in diseases classified elsewhere
References
- World Health Organization (WHO): International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), Chapter XII – Diseases of the skin and subcutaneous tissue (L00–L99). Geneva: WHO.
- Hertl, M. (Ed.): Autoimmune Diseases of the Skin. Pathogenesis, Diagnosis, Management. 3rd ed. Springer, Vienna, 2011.
- Feliciani, C. et al.: Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. British Journal of Dermatology, 172(4), 867–877, 2015.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.